J.A. van Noord - Concepedia

Concepedia

Author

J.A. van Noord

Atrium Medisch Centrum Parkstad

Also Known As

A. J. M. Schreurs, J A Van Noord, J A van Noord, J. A. VAN NOORD, J. A. Van Noord, J. A. van Noord, J.A. Van Noord, J.A. van Noord, JAN A. van NOORD, Jan A van Noord

61

Publications

4.8K

Citations

28

H-Index

44

Concepts

All Affiliations

Atrium Medisch Centrum Parkstad Boehringer Ingelheim (Netherlands)De Wever-Ziekenhuis Boehringer Ingelheim (Germany)Hartcentrum Hasselt

JV

About

J.A. van Noord is an author at Atrium Medisch Centrum Parkstad specializing in medicine, pulmonary disease, and asthma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	24	2.2K
2	Allergy	8	8	793
3	Engineering	1	1	94
4	Health Sciences	1	1	49
5	Public Health	1	1	25

J.A. van Noord

×

40

Publications

4.8K

Citations

28

H-Index

	Year	Citations
Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium Walter Vincken, J.A. van Noord, A.P.M. Greefhorst, European Respiratory Journal	2002	736
A 6-Month, Placebo-Controlled Study Comparing Lung Function and Health Status Changes in COPD Patients Treated With Tiotropium or Salmeterol James F. Donohue, J.A. van Noord, Eric Bateman, CHEST Journal Advanced Lung DiseaseHealth Status ChangesPulmonary MedicineCopd Patients TreatedMedicine	2002	469
Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD J.A. van Noord, J. Aumann, J.J. Smeets, European Respiratory Journal	2005	339
Effects of Tiotropium With and Without Formoterol on Airflow Obstruction and Resting Hyperinflation in Patients With COPD J.A. van Noord, Joseph Aumann, Jan Verhaert, CHEST Journal Pulmonary CirculationCardiovascular DiseaseAdvanced Lung DiseaseAirflow ObstructionWithout Formoterol	2006	281
Tiotropium improves lung function in patients with severe uncontrolled asthma: A randomized controlled trial Huib A.M. Kerstjens, Bernd Disse, W Schröder-Babo, Journal of Allergy and Clinical Immunology AsthmaAllergyInflammatory Lung DiseaseLung InflammationAdvanced Lung Disease	2011	275
A randomised controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary disease J.A. van Noord Thorax	2000	248
Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium J.A. van Noord, D Munck, Th.A. Bantje, European Respiratory Journal AsthmaAllergyAdvanced Lung DiseaseLong-term TreatmentPulmonary Pharmacology	2000	212
An empirical comparison of the St George's Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ) in a clinical trial setting Maureen Rutten‐van Mölken, Bernard A. Roos, J.A. van Noord Thorax	1999	211
Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction César Villarán, Shane O’Neill, Arthur Helbling, Journal of Allergy and Clinical Immunology AsthmaAllergyExercise PhysiologyPulmonary PharmacologyLung Mechanics	1999	181
Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial Anthony D’Urzo, Gary T. Ferguson, J.A. van Noord, Respiratory Research	2011	177

Page 1